Michael Bigham, Executive Chairman of the Board at Paratek Pharmaceuticals, Inc. (PRTK), sold 52,500 shares at $5.93 ($311K) on 2020-11-13, disclosed to the SEC on 2020-11-16.
Open-market sale of $311k PRTK by Executive Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.93 | 26,250 | $156K | 50.0% |
| 2 | $5.93 | 26,250 | $156K | 50.0% |
| Total | $5.93 avg | 52,500 | $311K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |